Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone Sarcoma

SIMPLE SUMMARY: Gemcitabine-docetaxel chemotherapy is an important regimen for the treatment of soft tissue and bone sarcomas. We aimed to determine if gemcitabine-docetaxel when administered every 14-day would be as effective and less toxic compared to the 21-day schedule. Our study shows that inde...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Minggui, Trieu, Maily K., Sidhu, Manpreet, Yu, Jeanette, Seto, Tiffany, Ganjoo, Kristen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074251/
https://www.ncbi.nlm.nih.gov/pubmed/33924080
http://dx.doi.org/10.3390/cancers13081983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074251/
https://www.ncbi.nlm.nih.gov/pubmed/33924080
http://dx.doi.org/10.3390/cancers13081983

Ejemplares similares